# A unique pediatric thoracic fibrosarcoma: Case report and successful therapeutic strategy

**Authors:** Khaled Alomar, Kamar Shaker, Nidal Alkhani

PMC · DOI: 10.1016/j.ijscr.2025.111999 · International Journal of Surgery Case Reports · 2025-10-02

## TL;DR

A rare case of pediatric fibrosarcoma in the pleura was successfully treated with surgery and chemotherapy, highlighting the importance of early diagnosis.

## Contribution

This is the first reported case of congenital infantile fibrosarcoma originating in the pleura.

## Key findings

- The patient was successfully treated with complete surgical excision and adjuvant VAC chemotherapy.
- Pleural localization of congenital infantile fibrosarcoma is exceptionally uncommon.
- Early recognition and prompt management improved the patient's outcome.

## Abstract

Congenital Infantile Fibrosarcoma (CIFS) is an exceptionally rare pediatric malignancy, representing approximately 10 % of all soft tissue cancers in young children. Its clinical manifestations vary according to tumor location. When tumors occur in unusual anatomical sites, symptoms may be misleading and delay proper diagnosis and treatment.

We report an 11-month-old male with a month-long persistent dry cough and high fever unresponsive to antibiotics. Chest CT revealed a pleural mass with mild effusion. Thoracotomy achieved complete excision (R0). Histopathology showed low-grade fibrosarcoma; immunohistochemistry was positive for Vimentin and SMA, focally CD34, and negative for S100, Desmin, and Myogenin, with low Ki-67 (<3 %). ETV6-NTRK3 fusion testing was unavailable. The patient received six cycles of adjuvant VAC chemotherapy and tolerated treatment well, with only mild transient neutropenia.

Diagnosis depends on histopathological and immunohistochemical analysis, as CIFS mimics several other soft tissue sarcomas. Our review of medical literature found no prior cases of CIFS originating in the pleura, underlining the uniqueness of this case. Management followed a standard multidisciplinary approach consisting of complete surgical excision and adjuvant chemotherapy (VAC protocol). At 12-month follow-up, the patient remained recurrence-free.

Persistent pneumonia-like symptoms unresponsive to standard treatment in infants should prompt consideration of underlying malignancy. Early recognition and prompt management are essential for improving outcomes in such rare presentations.

•Congenital infantile fibrosarcoma (CIFS) is a rare tumor presenting shortly after birth and developing in early childhood.•Pleural localization of CIFS is exceptionally uncommon, with only few cases described in the literature.•Persistent pneumonia-like symptoms not responding to antibiotics should prompt consideration of malignant etiologies.•Surgical removal is the primary treatment, often combined with chemotherapy.•Local recurrence occurs in up to 40 % of cases.

Congenital infantile fibrosarcoma (CIFS) is a rare tumor presenting shortly after birth and developing in early childhood.

Pleural localization of CIFS is exceptionally uncommon, with only few cases described in the literature.

Persistent pneumonia-like symptoms not responding to antibiotics should prompt consideration of malignant etiologies.

Surgical removal is the primary treatment, often combined with chemotherapy.

Local recurrence occurs in up to 40 % of cases.

## Linked entities

- **Proteins:** PRELID1 (PRELI domain containing 1), SMN1 (survival of motor neuron 1, telomeric), CD34 (CD34 molecule), S100A1 (S100 calcium binding protein A1), LOC101066771 (desmin-like), myog.S (myogenin S homeolog)
- **Diseases:** pneumonia (MONDO:0005249)

## Full-text entities

- **Genes:** ETV6 (ETS variant transcription factor 6) [NCBI Gene 2120] {aka TEL, TEL/ABL, THC5}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, VIM (vimentin) [NCBI Gene 7431], NTRK3 (neurotrophic receptor tyrosine kinase 3) [NCBI Gene 4916] {aka GP145-TrkC, TRKC, gp145(trkC)}, CD34 (CD34 molecule) [NCBI Gene 947], MYOG (myogenin) [NCBI Gene 4656] {aka MYF4, bHLHc3, myf-4}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, SMN1 (survival of motor neuron 1, telomeric) [NCBI Gene 6606] {aka BCD541, GEMIN1, SMA, SMA1, SMA2, SMA3}
- **Diseases:** malignancy (MESH:D009369), fever (MESH:D005334), pneumonia (MESH:D011014), pleural mass (MESH:D010995), CIFS (MESH:D005354), effusion (MESH:D000080324), soft tissue sarcomas (MESH:D012509), neutropenia (MESH:D009503), dry cough (MESH:D003371), pediatric (MESH:D063766)
- **Chemicals:** VAC (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12528867/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12528867/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12528867/full.md

---
Source: https://tomesphere.com/paper/PMC12528867